Wound Care in the Era of MRSA: My Pearls and Pitfalls
- Tue, 2/16/10 - 10:58am
- 1 Comments
- 2423 reads
Although it’s been almost 10 years, I’ll never forget the tone and inflection from my attending when she impressed upon me just how serious she considered ‘staph’ to be as a pathogen. At the time I was a new Infectious Diseases Fellow and I remember thinking that surely there must be some other bugs that would rate the same serious consideration. However, what I didn’t appreciate then—I do now.
Understanding Staph
Infection Control
- Fri, 9/25/09 - 6:08am
- 0 Comments
- 1590 reads
Today’s wound care clinics have a myriad of clinical practice and regulatory considerations.
Infection control is one area that affects everyday clinical practice, but is also a regulatory consideration of growing significance. The prevalence of drug resistant microorganisms, such as Methicillin Resistant Staphylococcus Aureus (MRSA), has heightened the concern related to chronic wound infections and infection control practices in the outpatient wound clinic.
One of the Joint Commission’s National Patient Safety Goals require clinicians to reduce the risk of healthcare associated infec
